Physician profile
Michael Edwin Davis
NPI 1356336895
$448.57
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $318 · 2020: $33.73 · 2021: $46.13 · 2022: $30.40 · 2023: $19.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $249.99 | 2019-2020 | |
| Daiichi Sankyo INC. | $43.07 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $26.95 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.42 | 2019 | |
| Idorsia Pharmaceuticals US INC | $19.98 | 2023 | Quviviq |
| Biohaven Pharmaceutical Holding Company Ltd. | $15.31 | 2022 | |
| Alexion Pharmaceuticals, INC. | $15.09 | 2022 | |
| Abbott Laboratories | $14.40 | 2021 | |
| Boston Scientific Corporation | $13.48 | 2019 | |
| Kyowa Kirin, INC. | $13.22 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $11.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.